These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6116494)

  • 1. Theoretical implications of tolerance development in DA, ACh and GABA turnover after neuroleptic chronic treatment.
    Agnati LF; Zini I; Lenzi P; Cortelli P; Battistini N; Bernardi P
    Boll Soc Ital Biol Sper; 1981 Jun; 57(11):1261-6. PubMed ID: 6116494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Current theories on the role of dopamine in the mechanism of action of neuroleptic drugs].
    Płaźnik A; Kostowski W
    Psychiatr Pol; 1984; 18(1):39-47. PubMed ID: 6146150
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of repeated treatment with neuroleptics on dopamine metabolism in cell bodies and terminals of dopaminergic systems in the rat brain.
    Scatton B
    Adv Biochem Psychopharmacol; 1980; 24():31-6. PubMed ID: 6105783
    [No Abstract]   [Full Text] [Related]  

  • 4. Nonstriatal dopaminergic neurons: Section X. Morphine, amphetamine, and noncataleptogenic neuroleptics: Introduction: morphine, amphetamine, and noncataleptogenic neuroleptics.
    Costa E
    Adv Biochem Psychopharmacol; 1977; 16():557-63. PubMed ID: 18900
    [No Abstract]   [Full Text] [Related]  

  • 5. Changes in the sensitivity to apomorphine of dopamine receptors modulating dopamine and acetylcholine release after chronic treatment with bromocriptine or haloperidol.
    Cubeddu LX; Hoffmann IS; James MK; Niedzwiecki DM
    J Pharmacol Exp Ther; 1983 Sep; 226(3):680-5. PubMed ID: 6887008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Correlation of dopamin- and GABA-ergic mechanisms in the depressive effect of neuroleptics on pedal self-stimulation of the ventral tegmentum of the mesencephalon].
    Talalaenko AN; Boreĭsha IK
    Farmakol Toksikol; 1983; 46(2):36-9. PubMed ID: 6133777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of divalproex and atypical antipsychotic drugs on dopamine and acetylcholine efflux in rat hippocampus and prefrontal cortex.
    Huang M; Li Z; Ichikawa J; Dai J; Meltzer HY
    Brain Res; 2006 Jul; 1099(1):44-55. PubMed ID: 16824491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sustained gamma-aminobutyric acid receptor stimulation and chronic neuroleptic effects.
    Lloyd KG; Worms P
    Adv Biochem Psychopharmacol; 1980; 24():253-8. PubMed ID: 6105780
    [No Abstract]   [Full Text] [Related]  

  • 9. Antipsychotic drug effects on dopamine and serotonin receptors: in vitro binding and in vivo turnover studies.
    Bacopoulos NG
    J Pharmacol Exp Ther; 1981 Dec; 219(3):708-14. PubMed ID: 6170752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of tolerance to benzodiazepines. I. Changes in the systems of central nervous system neurotransmitters during long-term administration of nitrazepam.
    Nowakowska E; Chodera A; Szczawińska K; Cenajek D
    Acta Physiol Pol; 1983; 34(3):345-51. PubMed ID: 6202092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A biochemical theory of schizophrenia].
    Kornhuber HH; Kornhuber J; Kim JS; Kornhuber ME
    Nervenarzt; 1984 Nov; 55(11):602-6. PubMed ID: 6151120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of relation between dopaminergic and gabaergic mechanisms in chick retina.
    Nistico G; De Sarro A; Urna G; Pujia A; Ientile R
    Res Commun Chem Pathol Pharmacol; 1983 Apr; 40(1):29-39. PubMed ID: 6135247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CI-1007, a dopamine partial agonist and potential antipsychotic agent. I. Neurochemical effects.
    Rugsley TA; Davis MD; Akunne HC; Cooke LW; Whetzel SZ; MacKenzie RG; Shih YH; van Leeuwen DH; DeMattos SB; Georgic LM
    J Pharmacol Exp Ther; 1995 Aug; 274(2):898-911. PubMed ID: 7636753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Action of etmozin and ethacizin on dopaminergic adenylate cyclase of the striate system of the brain].
    Baldenkov GN; Ratner EI; Rozenshtraukh LV; Tkachuk VA
    Biull Eksp Biol Med; 1984 Oct; 98(10):448-50. PubMed ID: 6149776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of chronic treatment with 1-sulpiride and haloperidol on central dopamine turnover evaluated in dopamine cell body and nerve terminal-rich areas.
    Agnati LF; Andersson K; Fuxe K; Benfenati F; Cortelli P; D'Alessandro R; Ogren SO
    Adv Biochem Psychopharmacol; 1980; 24():75-80. PubMed ID: 7405679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopamine metabolism in the rat retina and brain after acute and repeated treatment with neuroleptics.
    Scatton B; Dedek J; Korf J
    Adv Biochem Psychopharmacol; 1978; 19():373-5. PubMed ID: 29452
    [No Abstract]   [Full Text] [Related]  

  • 17. Tardive dyskinesia: a biological appraoch.
    Barbaccia ML; Trabucchi M
    Prog Clin Biol Res; 1980; 39():181-93. PubMed ID: 6105670
    [No Abstract]   [Full Text] [Related]  

  • 18. Mayo Seminars in Psychiatry: dopamine and schizophrenia--a review.
    Fredrickson P; Richelson E
    J Clin Psychiatry; 1979 Sep; 40(9):399-405. PubMed ID: 39063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term adaptive changes in striatal dopamine function in response to chronic neuroleptic intake in rats.
    Jenner P; Kerwin R; Rupniak NM; Murugaiah K; Hall MD; Fleminger S; Marsden CD
    J Neural Transm Suppl; 1983; 18():205-12. PubMed ID: 6135741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chlorpromazine-induced neuroleptic malignant syndrome and its response to diazepam.
    Lew TY; Tollefson G
    Biol Psychiatry; 1983 Dec; 18(12):1441-6. PubMed ID: 6661471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.